- Home
- HRB vs LNTH Comparison
HRB vs LNTH Comparison
Compare HRB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRB
- LNTH
- Stock Information
- Founded
- HRB 1955
- LNTH 1956
- Country
- HRB United States
- LNTH United States
- Employees
- HRB N/A
- LNTH N/A
- Industry
- HRB Other Consumer Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HRB Consumer Discretionary
- LNTH Health Care
- Exchange
- HRB Nasdaq
- LNTH Nasdaq
- Market Cap
- HRB 8.2B
- LNTH 7.5B
- IPO Year
- HRB N/A
- LNTH 2015
- Fundamental
- Price
- HRB $57.48
- LNTH $79.52
- Analyst Decision
- HRB Sell
- LNTH Strong Buy
- Analyst Count
- HRB 2
- LNTH 5
- Target Price
- HRB $62.00
- LNTH $133.80
- AVG Volume (30 Days)
- HRB 1.8M
- LNTH 1.2M
- Earning Date
- HRB 05-07-2025
- LNTH 05-07-2025
- Dividend Yield
- HRB 2.61%
- LNTH N/A
- EPS Growth
- HRB N/A
- LNTH N/A
- EPS
- HRB 4.04
- LNTH 3.53
- Revenue
- HRB $3,712,614,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- HRB $4.03
- LNTH $5.81
- Revenue Next Year
- HRB $2.80
- LNTH $12.26
- P/E Ratio
- HRB $14.22
- LNTH $22.52
- Revenue Growth
- HRB 3.71
- LNTH 12.53
- 52 Week Low
- HRB $48.23
- LNTH $74.34
- 52 Week High
- HRB $68.45
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- HRB 43.75
- LNTH 28.34
- Support Level
- HRB $60.57
- LNTH $78.92
- Resistance Level
- HRB $64.62
- LNTH $108.91
- Average True Range (ATR)
- HRB 1.85
- LNTH 3.92
- MACD
- HRB -0.62
- LNTH -3.09
- Stochastic Oscillator
- HRB 7.03
- LNTH 3.00
About HRB H&R Block Inc.
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.